An alliance of drug companies and research advocacy groups is calling for Congress to appropriate $2.8 billion for FDA in fiscal 2018 -- a $78 million increase from fiscal 2016. The additional funds would help the agency keep up with growing responsibilities and could improve food safety, drug quality and implementation of 21st Century Cures, a spokesperson for the alliance told Inside Health Policy . The White House on Monday (Feb. 27) signaled it will seek deep funding cuts at...